Isotopes of lutetium

(Redirected from Lutetium-175)

Naturally occurring lutetium (71Lu) is composed of one stable isotope 175Lu (97.41% natural abundance) and one long-lived radioisotope, 176Lu with a half-life of 37 billion years (2.59% natural abundance). Forty radioisotopes have been characterized, with the most stable, besides 176Lu, being 174Lu with a half-life of 3.31 years, and 173Lu with a half-life of 1.37 years. All of the remaining radioactive isotopes have half-lives that are less than 9 days, and the majority of these have half-lives that are less than half an hour. This element also has 18 meta states, with the most stable being 177mLu (t1/2 160.4 days), 174mLu (t1/2 142 days) and 178mLu (t1/2 23.1 minutes).

Isotopes of lutetium (71Lu)
Main isotopes[1]Decay
abun­dancehalf-life (t1/2)modepro­duct
173Lusynth1.37 yε173Yb
174Lusynth3.31 yβ+174Yb
175Lu97.4%stable
176Lu2.60%3.701×1010 yβ176Hf
177Lusynth6.65 dβ177Hf
Standard atomic weight Ar°(Lu)

The known isotopes of lutetium range in mass number from 149 to 190. The primary decay mode before the most abundant stable isotope, 175Lu, is electron capture (with some alpha and positron emission), and the primary mode after is beta emission. The primary decay products before 175Lu are isotopes of ytterbium and the primary products after are isotopes of hafnium. All isotopes of lutetium are either radioactive or, in the case of 175Lu, observationally stable, meaning that 175Lu is predicted to be radioactive but no actual decay has been observed.[4]

List of isotopes

Nuclide
[n 1]
ZNIsotopic mass (Da)
[n 2][n 3]
Half-life
[n 4][n 5]
Decay
mode

[n 6]
Daughter
isotope

[n 7]
Spin and
parity
[n 8][n 5]
Natural abundance (mole fraction)
Excitation energy[n 5]Normal proportionRange of variation
149Lu[5]7178450+170
−100
 ns
p148Yb11/2−
150Lu7179149.97323(54)#43(5) msp (80%)149Yb(2+)
β+ (20%)150Yb
150mLu34(15) keV80(60) μs
[30(+95−15) μs]
p149Yb(1, 2)
151Lu7180150.9675768280.6(5) msp (63.4%)150Yb(11/2−)
β+ (36.6%)151Yb
151mLu77(5) keV16(1) μsp150Yb(3/2+)
152Lu7181151.96412(21)#650(70) msβ+ (85%)152Yb(5−, 6−)
β+, p (15%)151Tm
153Lu7182152.95877(22)0.9(2) sα (70%)149Tm11/2−
β+ (30%)153Yb
153m1Lu80(5) keV1# sIT153Lu1/2+
153m2Lu2502.5(4) keV>0.1 μsIT153Lu23/2−
153m3Lu2632.9(5) keV15(3) μsIT153m2Lu27/2−
154Lu7183153.95752(22)#1# sβ+?154Yb(2−)
α?150Tm
154m1Lu58(13) keV1.12(8) sβ+154Yb(9+)
β+p?153Tm
β+α?150Er
α?150Tm
154m2Lu>2562 keV35(3) μsIT154Lu(17+)
155Lu7184154.954316(22)68.6(16) msα (76%)151Tm(11/2−)
β+ (24%)155Yb
155m1Lu20(6) keV138(8) msα (88%)151Tm(1/2+)
β+ (12%)155Yb
155m2Lu1781.0(20) keV2.70(3) ms(25/2−)
156Lu7185155.95303(8)494(12) msα (95%)152Tm(2)−
β+ (5%)156Yb
156mLu220(80)# keV198(2) msα (94%)152Tm(9)+
β+ (6%)156Yb
157Lu7186156.950098(20)6.8(18) sβ+157Yb(1/2+, 3/2+)
α153Tm
157mLu21.0(20) keV4.79(12) sβ+ (94%)157Yb(11/2−)
α (6%)153Tm
158Lu7187157.949313(16)10.6(3) sβ+ (99.09%)158Yb2−
α (.91%)154Tm
159Lu7188158.94663(4)12.1(10) sβ+ (99.96%)159Yb1/2+#
α (.04%)155Tm
159mLu100(80)# keV10# s11/2−#
160Lu7189159.94603(6)36.1(3) sβ+160Yb2−#
α (10−4%)156Tm
160mLu0(100)# keV40(1) s
161Lu7190160.94357(3)77(2) sβ+161Yb1/2+
161mLu166(18) keV7.3(4) msIT161Lu(9/2−)
162Lu7191161.94328(8)1.37(2) minβ+162Yb(1−)
162m1Lu120(200)# keV1.5 minβ+162Yb4−#
IT (rare)162Lu
162m2Lu300(200)# keV1.9 min
163Lu7192162.94118(3)3.97(13) minβ+163Yb1/2(+)
164Lu7193163.94134(3)3.14(3) minβ+164Yb1(−)
165Lu7194164.939407(28)10.74(10) minβ+165Yb1/2+
166Lu7195165.93986(3)2.65(10) minβ+166Yb(6−)
166m1Lu34.37(5) keV1.41(10) minβ+ (58%)166Yb3(−)
IT (42%)166Lu
166m2Lu42.9(5) keV2.12(10) min0(−)
167Lu7196166.93827(3)51.5(10) minβ+167Yb7/2+
167mLu0(30)# keV>1 min1/2(−#)
168Lu7197167.93874(5)5.5(1) minβ+168Yb(6−)
168mLu180(110) keV6.7(4) minβ+ (95%)168Yb3+
IT (5%)168Lu
169Lu7198168.937651(6)34.06(5) hβ+169Yb7/2+
169mLu29.0(5) keV160(10) sIT169Lu1/2−
170Lu7199169.938475(18)2.012(20) dβ+170Yb0+
170mLu92.91(9) keV670(100) msIT170Lu(4)−
171Lu71100170.9379131(30)8.24(3) dβ+171Yb7/2+
171mLu71.13(8) keV79(2) sIT171Lu1/2−
172Lu71101171.939086(3)6.70(3) dβ+172Yb4−
172m1Lu41.86(4) keV3.7(5) minIT172Lu1−
172m2Lu65.79(4) keV0.332(20) μs(1)+
172m3Lu109.41(10) keV440(12) μs(1)+
172m4Lu213.57(17) keV150 ns(6−)
173Lu71102172.9389306(26)1.37(1) yEC173Yb7/2+
173mLu123.672(13) keV74.2(10) μs5/2−
174Lu71103173.9403375(26)3.31(5) yβ+174Yb(1)−
174m1Lu170.83(5) keV142(2) dIT (99.38%)174Lu6−
EC (.62%)174Yb
174m2Lu240.818(4) keV395(15) ns(3+)
174m3Lu365.183(6) keV145(3) ns(4−)
175Lu71104174.9407718(23)Observationally stable[n 9]7/2+0.9741(2)
175m1Lu1392.2(6) keV984(30) μs(19/2+)
175m2Lu353.48(13) keV1.49(7) μs5/2−
176Lu[n 10][n 11]71105175.9426863(23)3.701(17)×1010 yβ176Hf7−0.0259(2)
EC (0.45(26)%)176Yb
176mLu122.855(6) keV3.664(19) hβ (99.9%)176Hf1−
EC (.095%)176Yb
177Lu71106176.9437581(23)6.6475(20) dβ177Hf7/2+
177m1Lu150.3967(10) keV130(3) ns9/2−
177m2Lu569.7068(16) keV155(7) μs1/2+
177m3Lu970.1750(24) keV160.44(6) dβ (78.3%)177Hf23/2−
IT (21.7%)177Lu
177m4Lu3900(10) keV7(2) min
[6(+3−2) min]
39/2−
178Lu71107177.945955(3)28.4(2) minβ178Hf1(+)
178mLu123.8(26) keV23.1(3) minβ178Hf9(−)
179Lu71108178.947327(6)4.59(6) hβ179Hf7/2(+)
179mLu592.4(4) keV3.1(9) msIT179Lu1/2(+)
180Lu71109179.94988(8)5.7(1) minβ180Hf5+
180m1Lu13.9(3) keV~1 sIT180Lu3−
180m2Lu624.0(5) keV≥1 ms(9−)
181Lu71110180.95197(32)#3.5(3) minβ181Hf(7/2+)
182Lu71111181.95504(21)#2.0(2) minβ182Hf(0,1,2)
183Lu71112182.95736(9)58(4) sβ183Hf(7/2+)
184Lu71113183.96103(22)#20(3) sβ184Hf(3+)
185Lu71114184.96354(32)#20# s7/2+#
186Lu71115185.96745(43)#6# s
187Lu71116186.97019(43)#7# s7/2+#
188Lu71117187.97443(43)#1# s
189Lu[6]71118
190Lu[7]71119
This table header & footer:

Lutetium-177

Lutetium (177Lu) chloride, sold under the brand name Lumark among others, is used for radiolabeling other medicines, either as an anti-cancer therapy or for scintigraphy (medical radio-imaging). Its most common side effects are anaemia (low red blood cell counts), thrombocytopenia (low blood platelet counts), leucopenia (low white blood cell counts), lymphopenia (low levels of lymphocytes, a particular type of white blood cell), nausea (feeling sick), vomiting and mild and temporary hair loss.[8][9]

References